Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 22819122)

1.

The cardioprotection of simvastatin in reperfused swine hearts relates to the inhibition of myocardial edema by modulating aquaporins via the PKA pathway.

Li XD, Yang YJ, Geng YJ, Cheng YT, Zhang HT, Zhao JL, Yuan JQ, Gao RL.

Int J Cardiol. 2013 Sep 10;167(6):2657-66. doi: 10.1016/j.ijcard.2012.06.121. Epub 2012 Jul 21.

PMID:
22819122
2.

[Ischemic preconditioning attenuates myocardial no-reflow and reperfusion injury after revascularization of acute myocardial infarction by reducing myocardial edema via the protein kinase A pathway].

Li XD, Yang YJ, Zhao JL, Zhang HT, Cheng YT, Tian Y, Meng XM, Cui HH, Wang TJ.

Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Nov;40(11):945-51. Chinese.

PMID:
23363677
3.
4.

Phosphorylation of endothelial NOS contributes to simvastatin protection against myocardial no-reflow and infarction in reperfused swine hearts: partially via the PKA signaling pathway.

Li XD, Yang YJ, Geng YJ, Zhao JL, Zhang HT, Cheng YT, Wu YL.

Acta Pharmacol Sin. 2012 Jul;33(7):879-87. doi: 10.1038/aps.2012.27. Epub 2012 Jun 4.

5.

PKA-mediated eNOS phosphorylation in the protection of ischemic preconditioning against no-reflow.

Li XD, Cheng YT, Yang YJ, Meng XM, Zhao JL, Zhang HT, Wu YJ, You SJ, Wu YL.

Microvasc Res. 2012 Jul;84(1):44-54. doi: 10.1016/j.mvr.2012.04.002. Epub 2012 Apr 14.

PMID:
22542438
6.

Tongxinluo reduces myocardial no-reflow and ischemia-reperfusion injury by stimulating the phosphorylation of eNOS via the PKA pathway.

Li XD, Yang YJ, Geng YJ, Jin C, Hu FH, Zhao JL, Zhang HT, Cheng YT, Qian HY, Wang LL, Zhang BJ, Wu YL.

Am J Physiol Heart Circ Physiol. 2010 Oct;299(4):H1255-61. doi: 10.1152/ajpheart.00459.2010. Epub 2010 Aug 6.

7.

[Effects and potential mechanisms of short-term use of simvastatin on myocardial no-reflow after ischemia-reperfusion in rats].

Liu YH, Zhang M, Liu LM, Zhou X, Jiao ZQ, Li YM, Pang W.

Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Aug;36(8):729-34. Chinese.

PMID:
19100117
8.

Consecutive pharmacological activation of PKA and PKC mimics the potent cardioprotection of temperature preconditioning.

Khaliulin I, Parker JE, Halestrap AP.

Cardiovasc Res. 2010 Nov 1;88(2):324-33. doi: 10.1093/cvr/cvq190. Epub 2010 Jun 16.

9.

Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt pathway.

Wolfrum S, Dendorfer A, Schutt M, Weidtmann B, Heep A, Tempel K, Klein HH, Dominiak P, Richardt G.

J Cardiovasc Pharmacol. 2004 Sep;44(3):348-55.

PMID:
15475833
10.

Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection.

Yu QJ, Si R, Zhou N, Zhang HF, Guo WY, Wang HC, Gao F.

Apoptosis. 2008 Feb;13(2):305-17. doi: 10.1007/s10495-007-0169-2.

PMID:
18165901
11.

Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors.

Zhong B, Wang DH.

Am J Physiol Regul Integr Comp Physiol. 2009 Dec;297(6):R1681-90. doi: 10.1152/ajpregu.90746.2008. Epub 2009 Oct 7.

12.

Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo.

Pagel PS, Krolikowski JG, Shim YH, Venkatapuram S, Kersten JR, Weihrauch D, Warltier DC, Pratt PF Jr.

Anesth Analg. 2007 Sep;105(3):562-9.

PMID:
17717207
13.

Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs.

Padilla F, Garcia-Dorado D, Agulló L, Barrabés JA, Inserte J, Escalona N, Meyer M, Mirabet M, Pina P, Soler-Soler J.

Cardiovasc Res. 2001 Aug 15;51(3):592-600.

14.

Pretreatment with simvastatin reduces myocardial no-reflow by opening mitochondrial K(ATP) channel.

Zhao JL, Yang YJ, Cui CJ, You SJ, Gao RL.

Br J Pharmacol. 2006 Oct;149(3):243-9. Epub 2006 Aug 21.

15.

Remote periconditioning reduces myocardial no-reflow by the activation of K ATP channel via inhibition of Rho-kinase.

Zhao JL, Yang YJ, Pei WD, Sun YH, You SJ, Gao RL.

Int J Cardiol. 2009 Apr 3;133(2):179-84. doi: 10.1016/j.ijcard.2007.12.024. Epub 2008 Feb 13.

PMID:
18276025
16.

Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium.

Hamid SA, Bower HS, Baxter GF.

Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H2598-606. Epub 2007 Jan 12.

17.

Adiponectin inhibits oxidative/nitrative stress during myocardial ischemia and reperfusion via PKA signaling.

Zhang Y, Wang XL, Zhao J, Wang YJ, Lau WB, Yuan YX, Gao EH, Koch WJ, Ma XL.

Am J Physiol Endocrinol Metab. 2013 Dec;305(12):E1436-43. doi: 10.1152/ajpendo.00445.2013. Epub 2013 Oct 15.

18.

[Effects of tongxinluo on mini-swine vascular endothelial integrity and myocardial no-reflow in early reperfusion of acute myocardial infarction].

Zhang HT, Yang YJ, Wu YL, Cheng YT, Kang S, Zhao JL, Meng L, Tian Y, Zhang YW, Ye J, Meng XM.

Zhonghua Yi Xue Za Zhi. 2009 May 26;89(20):1421-5. Chinese.

PMID:
19671339
19.

Time-dependent cardioprotection with calcium antagonism and experimental studies with clevidipine in ischemic-reperfused pig hearts: part II.

Segawa D, Sjöquist PO, Wang QD, Gonon A, Rydén L.

J Cardiovasc Pharmacol. 2002 Sep;40(3):339-45.

PMID:
12198319
20.

[Beneficial effects of diltiazem on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion].

Zhao JL, Yang YJ, You SJ, Jing ZC, Wu YJ, Yang WX, Meng L, Tian Y, Chen JL, Gao RL, Chen ZJ.

Zhonghua Yi Xue Za Zhi. 2005 Mar 16;85(10):679-83. Chinese.

PMID:
15932731
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk